Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Otsuka Holdings Co., Ltd.

http://www.otsuka.com/en/

Latest From Otsuka Holdings Co., Ltd.

Luye Claims A First With Chinese Denosumab Approval

Luye Pharma has claimed a world first after its Boan Biotech subsidiary obtained an approval from China’s NMPA for its Boyoubei denosumab biosimilar rival to Amgen’s Prolia.

Biosimilars Approvals

Dealmaking Quarterly Statistics, Q3 2022

During Q3, biopharma merger and acquisition value reached $15.4bn and drew in $37.6bn in potential deal value from alliances. Device company M&A values reached $550m, while in vitro diagnostic firms and research tools players completed M&A activity that totaled $1.9bn.

Deals Companies

Finance Watch: Emalex Raises $250m To Fund Phase III Tourette’s Trial

Private Company Edition: The Paragon Biosciences-founded Emalex previously raised $35m when ecopipam was in Phase II. Also, Catalio Capital launches a “special situations” fund, Zenas raises $118m to develop a pipeline of autoimmune disease treatments and Lusaris emerges with $60m.

Financing Innovation

Solving The Data Problem For AI In Drug Discovery

While artificial intelligence has proven its value in drug discovery, for most companies, the power of their AI systems is only as strong as the data those systems are trained on. However, stakeholders – from individual companies to consortiums and service vendors -- are finding creative approaches to overcome the so-called data problem and strengthen their AI models.

Artificial Intelligence Innovation
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Other Names / Subsidiaries
    • Alamo Pharmaceuticals, LLC
    • Astex Pharmaceuticals, Inc.
    • Avanir Pharmaceuticals, Inc.
    • Daiya Foods Inc.
    • Diatranz Otsuka Limited
    • JIMRO Co., Ltd.
    • Korea Otsuka Pharmaceutical Co., Ltd.
    • Mitsui & Co., Ltd
    • Montigen Pharmaceuticals
    • Neurovance, Inc.
    • Otsuka Australia Pharmaceutical Pty Ltd
    • Otsuka Pharmaceutical Factory, Inc.
    • Otsuka Medical Devices Co., Ltd.
    • Otsuka Pharmaceutical Co., Ltd
    • Otsuka Pharmaceutical India Private Limited
    • ReCor Medical, Inc.
    • Singapore Otsuka Pharmaceutical Co., Ltd.
    • SuperGen, Inc.
    • Taiwan Otsuka Pharmaceutical Co., Ltd.
    • Taiho Pharmaceutical Co., Ltd.
    • Taiho Pharma Canada, Inc.
    • Visterra Inc.
UsernamePublicRestriction

Register